Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation

Robert A. Ambros, Mark E. Sherman, Christopher M. Zahn, Pincas Bitterman, Robert J Kurman

Research output: Contribution to journalArticle

Abstract

Endometrial intraepithelial carcinoma (EIC) is a recently described lesion characterized by replacement of endometrial surface epithelium or glands by malignant cells resembling high-grade invasive endometrial carcinoma. EIC has been identified in a high proportion of uteri containing serous carcinoma, but its association with other endometrial tumors is unknown. To determine the strength and specificity of the association of EIC with tumors displaying serous differentiation, the appearance of the endometrium in 38 uteri with serous carcinoma, 113 with endometrioid carcinoma, and 34 with malignant mixed mesodermal tumor (MMMT) were compared. EIC was present in 34 (89%) uteri with serous carcinoma compared with 7 (6%) uteri removed for endometrioid carcinoma (P = .0001). Hyperplasia without atypia was found in only 2 (5%) of 38 serous carcinomas compared with 38 (34%) of 113 endometrioid carcinomas. Similarly, atypical hyperplasia was not found in any uterus with serous carcinoma, but was present in 14 (12%) uteri with endometrioid carcinoma (P = .02). The endometrium was inactive or atrophic in 29 (76%) patients with serous carcinoma compared with 33 (29%) with endometrioid carcinoma (P = .0001). EIC was found in five (56%) of nine MMMTs with a serous epithelial component (serous-MMMT) compared with one (4%) of 25 MMMTs with an endometrioid epithelial component (endometrioid-MMMT). As with endometrioid and serous carcinomas, hyperplasia with and without atypia was more common with endometrioid-MMMTs as compared with serousMMMTs. Hyperplasia was found in 25 (100%) and atypical hyperplasia in 8 (32%) of 25 endometrioid-MMMTs, but in none of the nine serous-MMMTs. This study shows that EIC is frequently and specifically associated with uterine tumors displaying serous differentiation. The findings suggest that EIC represents a form of intraepithelial tumor growth characteristic of serous carcinoma and serous MMMT and that EIC is the likely precursor of these neoplasms. In addition, the findings provide further evidence supporting the view that MMMTs represent variants of carcinoma not sarcoma.

Original languageEnglish (US)
Pages (from-to)1260-1267
Number of pages8
JournalHuman Pathology
Volume26
Issue number11
DOIs
StatePublished - 1995

Fingerprint

Carcinoma in Situ
Endometrial Neoplasms
Endometrioid Carcinoma
Malignant Mixed Tumor
Uterus
Carcinoma
Hyperplasia
Neoplasms
Endometrium
Sarcoma
Epithelium
Growth

Keywords

  • atypical endometrial hyperplasia
  • cancer precursor
  • carcinogenesis
  • endometrial intraepithelial carcinoma
  • malignant mixed mesodermal tumor
  • uterine serous carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Endometrial intraepithelial carcinoma : A distinctive lesion specifically associated with tumors displaying serous differentiation. / Ambros, Robert A.; Sherman, Mark E.; Zahn, Christopher M.; Bitterman, Pincas; Kurman, Robert J.

In: Human Pathology, Vol. 26, No. 11, 1995, p. 1260-1267.

Research output: Contribution to journalArticle

Ambros, Robert A. ; Sherman, Mark E. ; Zahn, Christopher M. ; Bitterman, Pincas ; Kurman, Robert J. / Endometrial intraepithelial carcinoma : A distinctive lesion specifically associated with tumors displaying serous differentiation. In: Human Pathology. 1995 ; Vol. 26, No. 11. pp. 1260-1267.
@article{deecef69ce7c432b9d818c662eb1732b,
title = "Endometrial intraepithelial carcinoma: A distinctive lesion specifically associated with tumors displaying serous differentiation",
abstract = "Endometrial intraepithelial carcinoma (EIC) is a recently described lesion characterized by replacement of endometrial surface epithelium or glands by malignant cells resembling high-grade invasive endometrial carcinoma. EIC has been identified in a high proportion of uteri containing serous carcinoma, but its association with other endometrial tumors is unknown. To determine the strength and specificity of the association of EIC with tumors displaying serous differentiation, the appearance of the endometrium in 38 uteri with serous carcinoma, 113 with endometrioid carcinoma, and 34 with malignant mixed mesodermal tumor (MMMT) were compared. EIC was present in 34 (89{\%}) uteri with serous carcinoma compared with 7 (6{\%}) uteri removed for endometrioid carcinoma (P = .0001). Hyperplasia without atypia was found in only 2 (5{\%}) of 38 serous carcinomas compared with 38 (34{\%}) of 113 endometrioid carcinomas. Similarly, atypical hyperplasia was not found in any uterus with serous carcinoma, but was present in 14 (12{\%}) uteri with endometrioid carcinoma (P = .02). The endometrium was inactive or atrophic in 29 (76{\%}) patients with serous carcinoma compared with 33 (29{\%}) with endometrioid carcinoma (P = .0001). EIC was found in five (56{\%}) of nine MMMTs with a serous epithelial component (serous-MMMT) compared with one (4{\%}) of 25 MMMTs with an endometrioid epithelial component (endometrioid-MMMT). As with endometrioid and serous carcinomas, hyperplasia with and without atypia was more common with endometrioid-MMMTs as compared with serousMMMTs. Hyperplasia was found in 25 (100{\%}) and atypical hyperplasia in 8 (32{\%}) of 25 endometrioid-MMMTs, but in none of the nine serous-MMMTs. This study shows that EIC is frequently and specifically associated with uterine tumors displaying serous differentiation. The findings suggest that EIC represents a form of intraepithelial tumor growth characteristic of serous carcinoma and serous MMMT and that EIC is the likely precursor of these neoplasms. In addition, the findings provide further evidence supporting the view that MMMTs represent variants of carcinoma not sarcoma.",
keywords = "atypical endometrial hyperplasia, cancer precursor, carcinogenesis, endometrial intraepithelial carcinoma, malignant mixed mesodermal tumor, uterine serous carcinoma",
author = "Ambros, {Robert A.} and Sherman, {Mark E.} and Zahn, {Christopher M.} and Pincas Bitterman and Kurman, {Robert J}",
year = "1995",
doi = "10.1016/0046-8177(95)90203-1",
language = "English (US)",
volume = "26",
pages = "1260--1267",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - Endometrial intraepithelial carcinoma

T2 - A distinctive lesion specifically associated with tumors displaying serous differentiation

AU - Ambros, Robert A.

AU - Sherman, Mark E.

AU - Zahn, Christopher M.

AU - Bitterman, Pincas

AU - Kurman, Robert J

PY - 1995

Y1 - 1995

N2 - Endometrial intraepithelial carcinoma (EIC) is a recently described lesion characterized by replacement of endometrial surface epithelium or glands by malignant cells resembling high-grade invasive endometrial carcinoma. EIC has been identified in a high proportion of uteri containing serous carcinoma, but its association with other endometrial tumors is unknown. To determine the strength and specificity of the association of EIC with tumors displaying serous differentiation, the appearance of the endometrium in 38 uteri with serous carcinoma, 113 with endometrioid carcinoma, and 34 with malignant mixed mesodermal tumor (MMMT) were compared. EIC was present in 34 (89%) uteri with serous carcinoma compared with 7 (6%) uteri removed for endometrioid carcinoma (P = .0001). Hyperplasia without atypia was found in only 2 (5%) of 38 serous carcinomas compared with 38 (34%) of 113 endometrioid carcinomas. Similarly, atypical hyperplasia was not found in any uterus with serous carcinoma, but was present in 14 (12%) uteri with endometrioid carcinoma (P = .02). The endometrium was inactive or atrophic in 29 (76%) patients with serous carcinoma compared with 33 (29%) with endometrioid carcinoma (P = .0001). EIC was found in five (56%) of nine MMMTs with a serous epithelial component (serous-MMMT) compared with one (4%) of 25 MMMTs with an endometrioid epithelial component (endometrioid-MMMT). As with endometrioid and serous carcinomas, hyperplasia with and without atypia was more common with endometrioid-MMMTs as compared with serousMMMTs. Hyperplasia was found in 25 (100%) and atypical hyperplasia in 8 (32%) of 25 endometrioid-MMMTs, but in none of the nine serous-MMMTs. This study shows that EIC is frequently and specifically associated with uterine tumors displaying serous differentiation. The findings suggest that EIC represents a form of intraepithelial tumor growth characteristic of serous carcinoma and serous MMMT and that EIC is the likely precursor of these neoplasms. In addition, the findings provide further evidence supporting the view that MMMTs represent variants of carcinoma not sarcoma.

AB - Endometrial intraepithelial carcinoma (EIC) is a recently described lesion characterized by replacement of endometrial surface epithelium or glands by malignant cells resembling high-grade invasive endometrial carcinoma. EIC has been identified in a high proportion of uteri containing serous carcinoma, but its association with other endometrial tumors is unknown. To determine the strength and specificity of the association of EIC with tumors displaying serous differentiation, the appearance of the endometrium in 38 uteri with serous carcinoma, 113 with endometrioid carcinoma, and 34 with malignant mixed mesodermal tumor (MMMT) were compared. EIC was present in 34 (89%) uteri with serous carcinoma compared with 7 (6%) uteri removed for endometrioid carcinoma (P = .0001). Hyperplasia without atypia was found in only 2 (5%) of 38 serous carcinomas compared with 38 (34%) of 113 endometrioid carcinomas. Similarly, atypical hyperplasia was not found in any uterus with serous carcinoma, but was present in 14 (12%) uteri with endometrioid carcinoma (P = .02). The endometrium was inactive or atrophic in 29 (76%) patients with serous carcinoma compared with 33 (29%) with endometrioid carcinoma (P = .0001). EIC was found in five (56%) of nine MMMTs with a serous epithelial component (serous-MMMT) compared with one (4%) of 25 MMMTs with an endometrioid epithelial component (endometrioid-MMMT). As with endometrioid and serous carcinomas, hyperplasia with and without atypia was more common with endometrioid-MMMTs as compared with serousMMMTs. Hyperplasia was found in 25 (100%) and atypical hyperplasia in 8 (32%) of 25 endometrioid-MMMTs, but in none of the nine serous-MMMTs. This study shows that EIC is frequently and specifically associated with uterine tumors displaying serous differentiation. The findings suggest that EIC represents a form of intraepithelial tumor growth characteristic of serous carcinoma and serous MMMT and that EIC is the likely precursor of these neoplasms. In addition, the findings provide further evidence supporting the view that MMMTs represent variants of carcinoma not sarcoma.

KW - atypical endometrial hyperplasia

KW - cancer precursor

KW - carcinogenesis

KW - endometrial intraepithelial carcinoma

KW - malignant mixed mesodermal tumor

KW - uterine serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0028829840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028829840&partnerID=8YFLogxK

U2 - 10.1016/0046-8177(95)90203-1

DO - 10.1016/0046-8177(95)90203-1

M3 - Article

C2 - 7590702

AN - SCOPUS:0028829840

VL - 26

SP - 1260

EP - 1267

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -